EDAP Receives the Prestigious Prix Galien for its Focal One® HIFU device
Dec 08, 2016 12:30 pm UTC| Business
LYON, France, Dec. 08, 2016 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the award of the prestigious 2016 Prix Galien, in the Medical Device category, for its Focal One...
SITO Mobile Takes Next Step In IP Monetization
Dec 08, 2016 12:30 pm UTC| Business
JERSEY CITY, N.J., Dec. 08, 2016 -- Today, SITO Mobile Ltd. (NASDAQ:SITO), a leading mobile engagement platform,announced the departure of board member Peter Holden, who is stepping down to now focus on the next stage...
Dec 08, 2016 12:05 pm UTC| Business
BEDMINSTER, N.J., Dec. 08, 2016 -- Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad spectrum therapeutics for the...
Dec 08, 2016 12:00 pm UTC| Business
Sub-Group Analysis of the Phase 2 AtEase Clinical Study Confirms TNX-102 SL’s Potential Efficacy in Combat-Related PTSD Patients Who are the Most Difficult to Treat New Results Presented in Poster Session at the American...
Dec 08, 2016 12:00 pm UTC| Business
Data presentation at CTAD 2016 NEW YORK, Dec. 08, 2016 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL) today announced a positive 57-week update from its Phase 2a study in mild-to-moderate...
Dec 08, 2016 12:00 pm UTC| Business
ATB200/AT2221 Safety Data Show No Infusion-AssociatedReactions Following 100+ Infusions Clinical Pharmacokinetic (PK) Profile as Predicted Based on Previously Reported Preclinical Data Biomarkers of Muscle...
Dec 08, 2016 12:00 pm UTC| Business
Speakers include world-renowned physicians Meeting to begin at 8:00 am ET; webcast will be available DEVON, Pa., Dec. 08, 2016 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical...